CEO: Eddie Gray

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Capital Market

Country: USA

Description: Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor ("TLR") stimulation.


Key numbers

Market Capitalization:505706553
Shares Outstanding: 83865100
Float: 82877672
Next Earning Date:2020-03-05
TTm EPS: -2.4048
TTm Dividend Rate:
200 days moving average:5.02
50 days moving average: 5.95
One day percent Change: -2.27



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,